Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review
Maryke J Nielsen1, Sarah Claxton, Barry Pizer
1From the Department of Oncology, Alder Hey Children's NHS Foundation Trust (MJN, BP); Institute of Infection and Global Health, University of Liverpool (SC, EDC, SP); Institute of Translational Medicine, University of Liverpool (SL, BP); Department of Microbiology, Alder Hey Children's NHS Foundation Trust (RPDC); and Department of Infectious Diseases, Alder Hey Children's NHS Foundation Trust (SP, EDC), Liverpool, UK.
Insights
Viridans Group Streptococci bacteremia in children with cancer is dangerous, especially in relapsed acute lymphoblastic leukemia. Further research is needed for better treatment strategies.
Area of Science:
- Pediatric Hematology-Oncology
- Infectious Diseases
- Microbiology
Background:
- Viridans Group Streptococci (VGS) infections carry high mortality in febrile neutropenia.
- Recent European pediatric data on VGS bacteremia (VGSB) and antimicrobial therapy are lacking.
- Children undergoing cancer treatment or hematopoietic stem cell transplant are at risk.
Purpose of the Study:
- To characterize VGSB in pediatric patients undergoing malignancy treatment or stem cell transplant.
- To describe outcomes and antimicrobial resistance patterns of VGSB.
- To inform empirical antimicrobial therapy in febrile neutropenia.
Main Methods:
- Retrospective study of patients aged 0–18 years with VGSB.
- Data collected from medical records at a tertiary pediatric hemato-oncology center (2003–2013).
- Analysis of VGS characteristics, patient outcomes, and antimicrobial susceptibility.
Main Results:
- 54 bacteremic episodes in 46 patients; most common diagnosis was relapsed acute lymphoblastic leukemia.
- Streptococcus mitis was the most frequent organism; 30% of isolates resistant to penicillin, 100% sensitive to vancomycin.
- 8 episodes (14.8%) of Viridans Group Streptococcal Shock Syndrome occurred, with 3 deaths.
Conclusions:
- VGSB is a potentially fatal condition in pediatric cancer patients.
- Relapsed acute lymphoblastic leukemia poses a high risk.
- Risk-stratification scores are needed to guide empirical antimicrobial therapy for VGSB.
Abstract:
Viridans Group Streptococci (VGS) are associated with high mortality rates in febrile neutropenia; yet there are no recent European pediatric studies to inform antimicrobial therapy. The aim of this study was to describe the characteristics, outcome, and resistance patterns of children with VGS bacteremia (VGSB) undergoing treatment of malignancy or hematopoietic stem cell transplant. Patients aged 0 to 18 years, admitted to a tertiary pediatric hemato-oncology center with VGSB, from 2003 to 2013, were included in the study. All data were collected retrospectively from medical records. A total of 54 bacteremic episodes occurred in 46 patients. The most common underlying diagnosis was relapsed acute lymphoblastic leukemia. Streptococcus mitis was the most frequent organism. A total of 30% of isolates were resistant to penicillin and 100% sensitive to vancomycin. There were 8 episodes (14.8%) of Viridans Group Streptococcal Shock Syndrome; 6 resulted in admission to intensive care and 3 of these patients died of multiorgan failure. The potentially fatal nature of VGSB is confirmed. The high risk in relapsed acute lymphoblastic leukemia is of note. Research is needed to develop risk-stratification scores that identify children at risk of Viridans Group Streptococcal Shock Syndrome to guide empirical antimicrobial therapy in febrile neutropenia.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Cytomegalovirus Disease
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Endocarditis IV: Nursing Management
